POS-239 MULTI-OMICS INTEGRATION REVEALS SIGNATURE OF GUT MICROBIAL METAGENOME AND FUNCTIONALITY IN RENAL PATIENTS RECEIVING PROTEIN RESTRICTION: A PROSPECTIVE RANDOMIZED STUDY

Immunology and Microbiology

• Intestine Flora 100%
• Metagenome 100%
• Multi-Omics 100%
• Blood Level 66%
• Glomerulus Filtration 66%
• Lactobacillus 66%
• Metabolite 66%
• Body Weight 33%
• Mucosa 33%
• RANTES 33%
• Porphyromonas gingivalis 33%
• Streptococcus mutans 33%
• Lactobacillus fermentum 33%
• Amino Acid Metabolism 33%
• Prevotella 33%
• Hepatocyte Growth Factor 33%
• Actinomyces 33%
• Streptococcus gordonii 33%
• Clostridium 33%
• Clostridiales 33%
• Bifidobacterium animalis 33%
• Roseburia 33%
• Alistipes 33%
• Bifidobacterium bifidum 33%
• Cytokine 33%
• Chemokine 33%
• Microbial Gene 33%
• Microbial Metabolism 33%
• Faecalibacterium prausnitzii 33%
• Lactococcus garvieae 33%

Medicine and Dentistry

• Chronic Kidney Disease 100%
• Gut 100%
• Protein Restriction 100%
• Metagenome 100%
• Tamsulosin 100%
• Gut Microbiota 50%
• Protein Intake 50%
• Glomerular Filtration Rate 33%
• Lactobacillus 33%
• Metabolite 33%
• Cytokine 16%
• Body Weight 16%
• Indican 16%
• Prospective Study 16%
• Mucosa 16%
• Lactococcus garvieae 16%
• Glutathione 16%
• Porphyromonas gingivalis 16%
• Diet Therapy 16%
• Scatter Factor 16%
• Sulfate 16%
• Actinomyces 16%
• Amino Acid Metabolism 16%
• RANTES 16%
• Streptococcus mutans 16%
• Metabolomics 16%
• Prevotella 16%
• Bifidobacterium animalis 16%
• Roseburia 16%
• Bifidobacterium bifidum 16%
• Chemokine 16%
• Lipopolysaccharide 16%
• Microbial Metabolism 16%
• Nonanoic Acid 16%
• Hexanoic Acid 16%
• Microbial Gene 16%
• Streptococcus gordonii 16%
• Alistipes 16%
• Lactobacillus fermentum 16%
• 3-Methylbutanoic Acid 16%
• Clostridium 16%
• Clostridiales 16%
• Caprylic Acid 16%
• Faecalibacterium prausnitzii 16%